Quality of life after nivolumab treatment for head and neck cancer

被引：4
作者：
Singer, Susanne [1 ]
机构：
[1] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Div Epidemiol & Hlth Serv Res, D-55131 Mainz, Germany
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 08期
关键词：
SQUAMOUS-CELL CARCINOMA; EORTC QLQ-H-AND-N35; RECURRENT; THERAPY; UPDATE; MODULE;
D O I：
10.1016/S1470-2045(17)30463-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：993 / +
页数：3
相关论文
共 50 条
  • [31] Pharyngoesophageal stricture after treatment for head and neck cancer
    Wang, Jing Jing
    Goldsmith, Tessa A.
    Holman, Allison S.
    Cianchetti, Marco
    Chan, Annie W.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (07): : 967 - 973
  • [32] Assessment of Quality of Life in Recurrent and Metastatic Head and Neck Cancer after Oral Metronomic Chemotherapy: A Prospective Interventional Study
    Nautiyal, Vipul
    Kumar, Viney
    Arora, Anshika
    Gupta, Meenu
    Mehra, Shivani
    Bansal, Saurabh
    Saini, Sunil
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [33] Efficacy of chemotherapy after progression with nivolumab in squamous cell carcinoma of the head and neck
    Suzuki, Shinsuke
    Toyoma, Satoshi
    Tomizawa, Hiroki
    Yamada, Toshiki
    Iikawa, Nobuko
    Shiina, Kazuhiro
    Saito, Hidekazu
    Koizumi, Koh
    Kawasaki, Yohei
    Yamada, Takechiyo
    [J]. AURIS NASUS LARYNX, 2020, 47 (03) : 485 - 488
  • [34] A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment
    Rathod, Shrinivas
    Livergant, Jonathan
    Klein, Jonathan
    Witterick, Ian
    Ringash, Jolie
    [J]. ORAL ONCOLOGY, 2015, 51 (10) : 888 - 900
  • [35] Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer
    Cabezas-Camarero, Santiago
    Iglesias-Moreno, Maria Cruz
    Cerezo Druet, Elena
    Sotelo, Miguel J.
    Merino-Menendez, Salome
    Cabrera-Martin, Maria Nieves
    Plaza-Hernandez, Jose Carlos
    Perez-Segura, Pedro
    [J]. ANTI-CANCER DRUGS, 2023, 34 (05) : 695 - 698
  • [36] Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States
    Haddad, Robert
    Cohen, Ezra E. W.
    Venkatachalam, Meena
    Young, Kate
    Singh, Prianka
    Shaw, James W.
    Korytowsky, Beata
    Abraham, Pranav
    Harrington, Kevin J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (05) : 442 - 447
  • [37] Nivolumab in recurrent/metastatic head and neck cancers
    Karabajakian, Andy
    Reverdy, Thibaut
    Gau, Max
    Fayette, Jerome
    [J]. FUTURE ONCOLOGY, 2018, 14 (07) : 603 - 609
  • [38] Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy
    Braam, Petra M.
    Roesink, Judith M.
    Raaijmakers, Cornelis P. J.
    Busschers, Wim B.
    Terhaard, Chris H. J.
    [J]. RADIATION ONCOLOGY, 2007, 2
  • [39] Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Koide, Yusuke
    Beppu, Shintaro
    Kadowaki, Shigenori
    Sone, Michihiko
    Hanai, Nobuhiro
    [J]. CANCERS, 2018, 10 (12):
  • [40] Health literacy: Impact on quality of life in head and neck cancer survivors
    Nilsen, Marci Lee
    Moskovitz, Jessica
    Lyu, Lingyun
    Harrison, Christine
    Randazza, Evan
    Das Peddada, Shyamal
    Johnson, Jonas T.
    [J]. LARYNGOSCOPE, 2020, 130 (10) : 2354 - 2359
12345